Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 791Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BRECKENRIDGE PHARMS

02 3ALEMBIC

03 1ALEMBIC PHARMS LTD

04 3ALKEM LABS LTD

05 3APOTEX

06 9BOEHRINGER INGELHEIM

07 3DR REDDYS LABS LTD

08 3GLENMARK PHARMS LTD

09 3HETERO LABS LTD III

10 3MSN

11 1MYLAN PHARMS INC

12 3TEVA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 110MG

Approval Date :

Application Number : 207922

RX/OTC/DISCN :

RLD :

TE Code :

Breckenridge Pharmaceutical

02

arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Approval Date :

Application Number : 207922

RX/OTC/DISCN :

RLD :

TE Code :

Breckenridge Pharmaceutical

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : PRADAXA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 75MG BASE

Approval Date : 2010-10-19

Application Number : 22512

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : PRADAXA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date : 2010-10-19

Application Number : 22512

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : PRADAXA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 110MG BASE

Approval Date : 2015-11-20

Application Number : 22512

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 75MG BASE

Approval Date :

Application Number : 207984

RX/OTC/DISCN :

RLD :

TE Code :

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 110MG BASE

Approval Date :

Application Number : 207984

RX/OTC/DISCN :

RLD :

TE Code :

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 75MG BASE

Approval Date : 2020-05-06

Application Number : 207961

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Approval Date : 2020-05-06

Application Number : 207961

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DABIGATRAN ETEXILATE MESYLATE

Brand Name : DABIGATRAN ETEXILATE MESYLATE

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 110MG BASE

Approval Date : 2024-08-13

Application Number : 207961

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank